Novel system for drug design
Artificial-intelligence approach designs novel compounds for broad applications, including drug development
Artificial-intelligence approach designs novel compounds for broad applications, including drug development
UNC startup Ribometrix is looking for drugs that target an untapped area of biology.
UNC startup acquired by leading patient experience and analytics company
Metal printing reduces the time to make brackets and increases their function
An improved cancer immunotherapy approach uses nanoparticles to capture tumor proteins.
UNC startup Impulsonic develops 3D sound simulation software and has been acquired by Valve Corporation.
Asthma patients may benefit from replenishment of a protein that relaxes airway muscle.
Researchers identify and reverse mechanisms of resistance in triple negative breast cancer.